Gregory Renza
Stock Analyst at Truist Financial
(4.85)
# 390
Out of 4,651 analysts
808
Total ratings
56.8%
Success rate
19.2%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Maintained: Buy | n/a | $31.94 | - | 6 | Aug 12, 2026 | |
| CATX Perspective Therapeutics | Maintained: Buy | $11 | $3.20 | +243.75% | 19 | Aug 11, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $244.96 | - | 42 | Aug 11, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $33.56 | - | 45 | Aug 11, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $39 | $22.08 | +76.63% | 36 | Aug 11, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $32 | $25.12 | +27.39% | 6 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $231 | $203.71 | +13.40% | 7 | Aug 11, 2026 | |
| CGON CG Oncology | Maintained: Buy | $85 | $75.03 | +13.29% | 22 | Aug 11, 2026 | |
| AAPG Ascentage Pharma Group International | Maintained: Buy | n/a | $18.75 | - | 4 | Aug 10, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $13 | $6.22 | +109.00% | 28 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52 | $51.24 | +1.48% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $3.85 | +55.84% | 38 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.34 | - | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $416 → $418 | $347.48 | +20.29% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $340 → $362 | $415.21 | -12.82% | 39 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $156 → $150 | $138.36 | +8.41% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $59 | $36.30 | +62.53% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $769 → $772 | $803.48 | -3.92% | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $3.90 | +79.49% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $3.74 | +6.95% | 17 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 | $33.19 | +150.08% | 2 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $27.05 | +25.69% | 27 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $155 | $118.96 | +30.30% | 12 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $28.24 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.01 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $1.09 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.58 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $4.97 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $0.7901 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $23.00 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.559 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $13 | $7.54 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $52.64 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $19.59 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $80 | $0.6799 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $0.00001 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $209.83 | n/a | 1 | Sep 8, 2015 |
Genmab
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $31.94
Upside: -
Perspective Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $11
Current: $3.20
Upside: +243.75%
Jazz Pharmaceuticals
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $244.96
Upside: -
Agios Pharmaceuticals
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $33.56
Upside: -
Viridian Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $39
Current: $22.08
Upside: +76.63%
Zymeworks
Aug 11, 2026
Maintained: Buy
Price Target: $32
Current: $25.12
Upside: +27.39%
Revolution Medicines
Aug 11, 2026
Reiterated: Buy
Price Target: $231
Current: $203.71
Upside: +13.40%
CG Oncology
Aug 11, 2026
Maintained: Buy
Price Target: $85
Current: $75.03
Upside: +13.29%
Ascentage Pharma Group International
Aug 10, 2026
Maintained: Buy
Price Target: n/a
Current: $18.75
Upside: -
Nuvation Bio
Aug 7, 2026
Maintained: Buy
Price Target: $13
Current: $6.22
Upside: +109.00%
Aug 6, 2026
Maintained: Hold
Price Target: $52
Current: $51.24
Upside: +1.48%
Aug 6, 2026
Maintained: Buy
Price Target: $6
Current: $3.85
Upside: +55.84%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.34
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $416 → $418
Current: $347.48
Upside: +20.29%
Aug 5, 2026
Maintained: Hold
Price Target: $340 → $362
Current: $415.21
Upside: -12.82%
Aug 5, 2026
Reiterated: Buy
Price Target: $156 → $150
Current: $138.36
Upside: +8.41%
Aug 5, 2026
Reiterated: Buy
Price Target: $63 → $59
Current: $36.30
Upside: +62.53%
Jul 31, 2026
Maintained: Buy
Price Target: $769 → $772
Current: $803.48
Upside: -3.92%
Jul 31, 2026
Maintained: Hold
Price Target: $7
Current: $3.90
Upside: +79.49%
Jul 31, 2026
Maintained: Hold
Price Target: $4
Current: $3.74
Upside: +6.95%
Jul 30, 2026
Maintained: Buy
Price Target: $83
Current: $33.19
Upside: +150.08%
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $27.05
Upside: +25.69%
Jul 2, 2026
Maintained: Buy
Price Target: $135 → $155
Current: $118.96
Upside: +30.30%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $28.24
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $8
Current: $1.01
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $5
Current: $1.09
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $6.58
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $20
Current: $4.97
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: $48 → $46
Current: $0.7901
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $26
Current: $23.00
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $16
Current: $0.559
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $12 → $13
Current: $7.54
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: $38
Current: $52.64
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $19.59
Upside: n/a
Mar 16, 2022
Maintained: Hold
Price Target: $5 → $80
Current: $0.6799
Upside: n/a
Nov 12, 2021
Maintained: Hold
Price Target: $1 → $15
Current: $0.00001
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $209.83
Upside: n/a